varicose vein treatment market overview:
The global varicose vein treatment market was valued at $376.64 million in 2017, and is expected to reach $589.06 million by 2025, registering a CAGR of 5.7% from 2018 to 2025. Varicose veins are abnormal, dilated blood vessels caused by weakening of the vessel’s walls. These veins appear to be swollen, twisted, cluster of blue or purple veins under the skin. Varicose vein disorder affects millions of people all around the world Symptoms usually appear at the age of 40 and generally appear in the legs. Varicose vein is harmful to health if they lead to venous stasis ulcers, phlebitis, thrombosis, venous hemorrhage, or fungal and bacterial infections. According to the American Society of Vascular surgery, at least 20 to 25 million Americans are suffering from varicose vein, among them 17% are men and 33% are women.
Considerable rise in prevalence of varicose vein problem, surge in geriatric population, advanced varicose vein treatment devices, engagement in occupation that increases the prevalence of varicose vein treatment and technological advancements globally, boost the growth of the market. Whereas, increase in level of awareness as well as development in the emerging markets create numerous opportunities in the varicose vein treatment market.
The global varicose vein treatment market is segmented based on procedure, product, end user, and region. Based on procedure, the market is endovenous ablation, injection sclerotherapy, surgical ligation/stripping. Based on product the market is segmented into ablation devices, sclerotherapy injection and others. Ablation devices is further divided into radiofrequency ablation devices, laser ablation devices and others. Based on end user, the market is divided into hospital, clinics, and ambulatory centers. Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea and rest of Asia-Pacific) and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Key Benefits for varicose vein treatment market:
The study presents an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2018 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
A comprehensive analysis of all the regions is provided to determine the existing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
varicose vein treatment Key Market Segments:
By Procedure
Injection Sclerotherapy
Endovenous Ablation
Surgical Ligation/Stripping
By Product
Sclerotherapy injection
Ablation Devices
Radiofrequency Ablation Devices
Laser Ablation Devices
Others
By End User
Hospitals
Clinics
Ambulatory centers
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
Alma Lasers Ltd
Angiodynamics, Inc
Biolitec AG
BTG PLC
Energist Ltd
Medtronic
Lumenis
Sciton Inc
Syneron
WONTECH Co., Ltd.
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
Teleflex
The Vein Company
F care Systems
Miravas
SharpLight Technologies
The global varicose vein treatment market was valued at $376.64 million in 2017, and is expected to reach $589.06 million by 2025, registering a CAGR of 5.7% from 2018 to 2025. Varicose veins are abnormal, dilated blood vessels caused by weakening of the vessel’s walls. These veins appear to be swollen, twisted, cluster of blue or purple veins under the skin. Varicose vein disorder affects millions of people all around the world Symptoms usually appear at the age of 40 and generally appear in the legs. Varicose vein is harmful to health if they lead to venous stasis ulcers, phlebitis, thrombosis, venous hemorrhage, or fungal and bacterial infections. According to the American Society of Vascular surgery, at least 20 to 25 million Americans are suffering from varicose vein, among them 17% are men and 33% are women.
Considerable rise in prevalence of varicose vein problem, surge in geriatric population, advanced varicose vein treatment devices, engagement in occupation that increases the prevalence of varicose vein treatment and technological advancements globally, boost the growth of the market. Whereas, increase in level of awareness as well as development in the emerging markets create numerous opportunities in the varicose vein treatment market.
The global varicose vein treatment market is segmented based on procedure, product, end user, and region. Based on procedure, the market is endovenous ablation, injection sclerotherapy, surgical ligation/stripping. Based on product the market is segmented into ablation devices, sclerotherapy injection and others. Ablation devices is further divided into radiofrequency ablation devices, laser ablation devices and others. Based on end user, the market is divided into hospital, clinics, and ambulatory centers. Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea and rest of Asia-Pacific) and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Key Benefits for varicose vein treatment market:
The study presents an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2018 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
A comprehensive analysis of all the regions is provided to determine the existing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
varicose vein treatment Key Market Segments:
By Procedure
Injection Sclerotherapy
Endovenous Ablation
Surgical Ligation/Stripping
By Product
Sclerotherapy injection
Ablation Devices
Radiofrequency Ablation Devices
Laser Ablation Devices
Others
By End User
Hospitals
Clinics
Ambulatory centers
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
Alma Lasers Ltd
Angiodynamics, Inc
Biolitec AG
BTG PLC
Energist Ltd
Medtronic
Lumenis
Sciton Inc
Syneron
WONTECH Co., Ltd.
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
Teleflex
The Vein Company
F care Systems
Miravas
SharpLight Technologies
Frequently Asked Questions about the Global Varicose Vein Treatment Market
What is the estimated value of the Global Varicose Vein Treatment Market?
What is the growth rate of the Global Varicose Vein Treatment Market?
What is the forecasted size of the Global Varicose Vein Treatment Market?
Note: Product cover images may vary from those shown
Chapter: 1: INTRODUCTION
1.3.1. List of key players profiled in the report:
CHAPTER: 2: EXECUTIVE SUMMARY
CHAPTER: 3: MARKET OVERVIEW
CHAPTER: 4: VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE
CHAPTER: 5: VARICOSE VEIN TREATMENT MARKET, BY PRODUCT
CHAPTER: 6: VARICOSE VEIN TREATMENT MARKET, BY END USER
CHAPTER: 7: VARICOSE VEIN TREATMENT MARKET, BY REGION
CHAPTER: 8: COMPANY PROFILES
Note: Product cover images may vary from those shown
According to this report titled 'Varicose Vein Treatment Market by Procedure, Product, and End User: Global Opportunity Analysis and Industry Forecast, 2018 - 2025,' the global varicose vein treatment market was valued at $376.64 million in 2017, and is expected to reach $589.06 million by 2025, growing at a CAGR of 5.7% from 2018 to 2025.
Varicose vein treatment are devices used to monitor asthma and prevent asthma attacks related complications. Growth in geriatric population and increase in cases of asthma drive the growth of the global varicose vein treatment market. Moreover, some of the factors such as increase in healthcare expenditure and better clinical outcomes fuel the market growth. However, product recall and lack of skilled healthcare professionals are expected to hinder the growth of the global market.
Based on procedure, the global varicose vein treatment market is segmented into endovenous ablation, injection sclerotherapy, surgical ligation/stripping. Currently, the injection sclerotherapy segment is leading the market and is estimated to grow at the highest rate. While, endovenous ablation devices are estimated to experience rapid growth rate.
Based on product, the global varicose vein treatment market is segmented into sclerotherapy injection, ablation devices and others. Ablation devices segment is further bifurcated into radiofrequency ablation devices, laser ablation devices and others. Currently, the ablation devices segment is estimated to grow at the fastest rate.
Based on end user, the global varicose vein treatment market is classified into hospitals, clinics, and ambulatory centers. Presently, the hospital segment dominates the global market and is estimated to grow at the highest and fastest rate during the forecast period.
Key Findings of the Varicose Vein Treatment Market:
Based on procedure, the sclerotherapy segment is expected to experience rapid growth in the market and is projected to grow at a CAGR of 5.5% from 2018 to 2025
Based on product, the ablation devices segment is expected to experience rapid growth in the market and is projected to grow at a CAGR of 7.3% from 2018 to 2025.
Based on end user, the hospital segment held approximately half of the global market share in 2017 and is expected to remain dominant throughout the forecast period.
Based on region, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 7.8% during the forecast period.
North America accounted for approximately one-half of the global market share in 2017 and is expected to remain dominant throughout the forecast period. This is attributed to the rise in demand for endovenous ablation devices, increase in number of varicose vein patients, and rise in geriatric population. While Asia-Pacific is expected to experience the highest growth rate during the forecast period majorly due to rise in number of geriatric varicose vein patients and increase in adoption of new and advanced technology for varicose vein treatment.'
Varicose vein treatment are devices used to monitor asthma and prevent asthma attacks related complications. Growth in geriatric population and increase in cases of asthma drive the growth of the global varicose vein treatment market. Moreover, some of the factors such as increase in healthcare expenditure and better clinical outcomes fuel the market growth. However, product recall and lack of skilled healthcare professionals are expected to hinder the growth of the global market.
Based on procedure, the global varicose vein treatment market is segmented into endovenous ablation, injection sclerotherapy, surgical ligation/stripping. Currently, the injection sclerotherapy segment is leading the market and is estimated to grow at the highest rate. While, endovenous ablation devices are estimated to experience rapid growth rate.
Based on product, the global varicose vein treatment market is segmented into sclerotherapy injection, ablation devices and others. Ablation devices segment is further bifurcated into radiofrequency ablation devices, laser ablation devices and others. Currently, the ablation devices segment is estimated to grow at the fastest rate.
Based on end user, the global varicose vein treatment market is classified into hospitals, clinics, and ambulatory centers. Presently, the hospital segment dominates the global market and is estimated to grow at the highest and fastest rate during the forecast period.
Key Findings of the Varicose Vein Treatment Market:
Based on procedure, the sclerotherapy segment is expected to experience rapid growth in the market and is projected to grow at a CAGR of 5.5% from 2018 to 2025
Based on product, the ablation devices segment is expected to experience rapid growth in the market and is projected to grow at a CAGR of 7.3% from 2018 to 2025.
Based on end user, the hospital segment held approximately half of the global market share in 2017 and is expected to remain dominant throughout the forecast period.
Based on region, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 7.8% during the forecast period.
North America accounted for approximately one-half of the global market share in 2017 and is expected to remain dominant throughout the forecast period. This is attributed to the rise in demand for endovenous ablation devices, increase in number of varicose vein patients, and rise in geriatric population. While Asia-Pacific is expected to experience the highest growth rate during the forecast period majorly due to rise in number of geriatric varicose vein patients and increase in adoption of new and advanced technology for varicose vein treatment.'
Note: Product cover images may vary from those shown
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
